Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Panel Rejects Vivus’s Qnexa, Citing Safety Worries
WSJ Online
Thursday, July 15, 2010 - 6:04pm
tags:
FDA, obesity, Vivus, Qnexa, advisory panels, Orexigen, Arena Pharmaceuticals, Contrave
Somaxon shares up on deal to promote insomnia drug
Marketwatch
Thursday, July 15, 2010 - 6:03pm
tags:
insomnia, Somaxon, Silenor, Publicis, contract sales
Glaxo gains on FDA panel vote for Avandia
Marketwatch
Thursday, July 15, 2010 - 6:01pm
tags:
GSK, Avandia, FDA, advisory panels
An Important Avandia Defense
Forbes
Thursday, July 15, 2010 - 11:20am
tags:
Avandia, GSK, diabetes
Judge scolds FTC in fight over Provigil copy
Fierce Pharma
Thursday, July 15, 2010 - 11:19am
tags:
Provigil, FTC, Watson Pharmaceuticals, generics, Cephalon
Arena rallies on FDA optimism; Vivus shares halted
Marketwatch
Thursday, July 15, 2010 - 11:17am
tags:
FDA, advisory panels, Qnexa, Arena Pharmaceuticals, Vivus
Peregrine 4Q loss widens on revenue dip
Yahoo/AP
Thursday, July 15, 2010 - 11:14am
tags:
Peregrine Pharmaceuticals, earnings
Shares of obesity drug developers rise following study on Arena Pharmaceuticals' lorcaserin
Yahoo/AP
Thursday, July 15, 2010 - 10:19am
tags:
obesity, Arena Pharmaceuticals, Qnexa, Contrave, Orexigen, Vivus
Perceptions of the Pharmaceutical Industry can make Normal Business Practices seem Unethical or Illegal
Pharmareform
Thursday, July 15, 2010 - 9:41am
tags:
ethics, off-label
With Avandia Now a Zombie, Can an FDA Safety Trial Survive Night of the Living Dead?
BNET Pharma
Thursday, July 15, 2010 - 9:38am
tags:
FDA, advisory panels, Avandia, GSK
Sepracor to become Sunovion Pharmaceuticals
Boston.com
Thursday, July 15, 2010 - 9:33am
tags:
Sepracor, Sunovion, M&A, Dainippon Sumitomo
Glaxo Plans $2.36 Billion Charge for Legal Issues
NY Times, NY
Thursday, July 15, 2010 - 9:31am
tags:
GSK, legal, Avandia, FDA, diabetes
WuXi expects 2Q profits to top Wall Street
Yahoo/AP
Thursday, July 15, 2010 - 9:29am
tags:
WuXi PharmaTech, earnings
Into The Wild West: Biotech Trading
CNBC
Thursday, July 15, 2010 - 9:06am
tags:
biotech, Amylin, Genzyme, Human Genome Sciences
Live Blog--Vivus' FDA Advisory Panel
TheStreet.com
Thursday, July 15, 2010 - 9:05am
tags:
Vivus, Orexigen, obesity, FDA, Arena Pharmaceuticals, advisory panels, Qnexa
Inhaled Insulin May Preserve Memory in Alzheimer Patients, Study Shows
Bloomberg
Thursday, July 15, 2010 - 9:02am
tags:
inhaled insulin, Alzheimer's disease, ViaNase
Alcon's Independent Directors Call Novartis Purchase Offer `Unacceptable'
Bloomberg
Thursday, July 15, 2010 - 8:51am
tags:
Alcon, Novartis, M&A
What The Avandia Vote Means
Forbes
Thursday, July 15, 2010 - 8:49am
tags:
Avandia, GSK, advisory panels, FDA, diabetes
Novartis Quarterly Profits Rise 19%
TheStreet.com
Thursday, July 15, 2010 - 8:48am
tags:
Novartis, earnings
Keryx's perifosine gets second orphan drug status
Yahoo/AP
Thursday, July 15, 2010 - 8:47am
tags:
Keryx, perifosine, orphan drugs, cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.